Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.48%
0%
-2.48%
6 Months
1.72%
0%
1.72%
1 Year
-9.23%
0%
-9.23%
2 Years
-13.87%
0%
-13.87%
3 Years
-31.79%
0%
-31.79%
4 Years
-29.34%
0%
-29.34%
5 Years
-8.53%
0%
-8.53%
Clere AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-59.88%
EBIT Growth (5y)
13.87%
EBIT to Interest (avg)
-6.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.59
Sales to Capital Employed (avg)
0.21
Tax Ratio
20.18%
Dividend Payout Ratio
7.66%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
7.11%
Valuation key factors
Factor
Value
P/E Ratio
70
Industry P/E
Price to Book Value
0.66
EV to EBIT
-31.49
EV to EBITDA
-32.39
EV to Capital Employed
0.70
EV to Sales
122.96
PEG Ratio
0.61
Dividend Yield
1.94%
ROCE (Latest)
-2.23%
ROE (Latest)
0.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2013
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'17 - YoY
Mar'17
Mar'16
Change(%)
Net Sales
0.30
0.00
Operating Profit (PBDIT) excl Other Income
-0.50
-18.30
97.27%
Interest
0.00
0.00
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
-0.20
-5.70
96.49%
Operating Profit Margin (Excl OI)
-1,633.60%
0.00%
-163.36%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2017 is 0.00% vs -100.00% in Mar 2016
Consolidated Net Profit
YoY Growth in quarter ended Mar 2017 is 96.49% vs -914.29% in Mar 2016
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
46.00
49.50
-7.07%
Operating Profit (PBDIT) excl Other Income
29.60
30.00
-1.33%
Interest
5.30
6.90
-23.19%
Exceptional Items
0.40
0.50
-20.00%
Consolidate Net Profit
23.10
2.80
725.00%
Operating Profit Margin (Excl OI)
280.70%
216.30%
6.44%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -7.07% vs 1.23% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 725.00% vs -33.33% in Dec 2023
About Clere AG 
Clere AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






